Continuing Education will open on the last day of conference, April 25th.
Continuing Education
EVENT LEARNING OBJECTIVES
1. Discuss the public health importance of the investigations presented.
2. Describe the EIS officers’ role in the development of investigational studies presented.
3. Describe the epidemiologic methods used during the EIS officer’s investigations.
4. Identify the limits on conclusions from available data.
5. Discuss any unresolved issues related to the EIS officer’s investigation.
6. Describe control and prevention recommendations based on investigation results.
7. Discuss the collaboration between laboratory and epidemiology disciplines.
8. Describe the importance of inter-professional collaboration in public health, the field and emergency response.
ACCREDITATION STATEMENT
In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: The Centers for Disease Control and Prevention designates this live activity for a maximum of 18.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention designates this activity for 18.5 nursing contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 1.4 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 18.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. Continuing Competency credits available are 0. CDC provider number 98614.
AAVSB/RACE: This program was reviewed and approved by AAVSB RACE program for 18.5 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program if you have any comments or concerns regarding this program’s validity or relevancy to the veterinary profession.
For Certified Public Health Professionals (CPH)
The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 24 CPH recertification credits for this program.
DISCLOSURE
In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
Presentations will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Amin’s discussion of an investigational vaccine product MenACWY-CRM/MenB-4C (Penmenvy, GSK). She will be discussing clinical trials that, at the time they were conducted, used an investigational vaccine product MenACWY-CRM/MenB-4C (Penmenvy, GSK). As of February 14, 2025 the product has been licensed by the FDA; however, its on-label use specifies a different dosing interval than what was used in some of the studies; and with the exception of Dr. Waranius’s discussion of the use of Anthrax Vaccine Adsorbed, Adjuvanted (trade name: Cyfendus). She will be discussing emergency use of Anthrax Vaccine Adsorbed, Adjuvanted in persons aged <18 and >65 years due to anthrax exposure during an outbreak. The product is labeled for use in individuals aged 18 - 65 years. CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
Instructions for Obtaining Continuing Education (CE)
To receive continuing education (CE) for CM4908-2025 Epidemic Intelligence Service (EIS) Conference (In person & Virtual), please visit CDC TRAIN and search for the course in the Course Catalog using CM4908.
Follow the steps below by 05/25/2025.
1. Register for and complete the course.
2. Complete the evaluation.
3. Visit Your Learning to access your certificates and transcript.
The registration code is EISCONF2025.
FEES: There are no fees for CE.